Salix and Progenics announced that the Food and Drug Administration (FDA) has approved Relistor (methylnaltrexone) subcutaneous injection for the treatment of opioid-induced constipation (OIC) in patients taking opioids for chronic non-cancer pain.
Otsuka and Lundbeck announced that the Food and Drug Administration (FDA) has approved Abilify Maintena (aripiprazole) for extended-release injectable suspension as a prefilled dual-chamber syringe.
LEO Pharma announced that Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension has been approved for the treatment of plaque psoriasis of the scalp in patients aged 12-17 years.
Aromatic-turmerone, a major bioactive compound of turmeric (Curcuma longa) and a common ingredient in curry, could help in treating neurodegenerative disease by regenerating endogenous neural stem cells (NSCs).
In a surprising move, major tobacco companies are including some of the strongest health warnings on their e-cigarette packaging that goes beyond the present warnings on cigarettes and other tobacco products.
A review published in PLOS One has found that B vitamin supplementation does not significantly reduce major cardiovascular outcomes despite prior observational studies suggesting supplementation may reduce cardiovascular risk.
The world's most expensive spice may also be an alternative treatment for mild-to-moderate depression, according to a new study.
Colorado health officials are reporting that several children, including some that tested positive for the Enterovirus 68 (EV-68) have also reported neurological symptoms not commonly associated with the virus, including muscle weakness and paralysis.
The United States Department of Health and Human Services announced the development of an investigational drug, AB103, to treat a condition called cytokine storm.
An increase in certain amino acids may be an early sign of pancreatic cancer, occurring before the disease is diagnosed and symptoms appear, reports a new study.